SCHEMBL21976166

SCHEMBL21976166

c1ccc(-c2ccc(N(c3ccc(-c4ccc(N(c5ccccc5)c5cccc6oc7ccccc7c56)c(-c5ccccc5)c4)cc3)c3cccc4oc5ccccc5c34)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 5/20 0.36
▸ PLA2G4A P47712 5/20 0.36
▸ PLA2G10 O15496 1/20 0.34
▸ TNKS O95271 2/20 0.32
▸ CDC14B O60729 1/20 0.32
▸ CDC14A Q9UNH5 1/20 0.32
▸ AR P10275 2/20 0.31
▸ GABRP O00591 1/20 0.31
▸ GABRD O14764 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ CA12 O43570 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ ABCB1 P08183 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ PARP1 P09874 1/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ CYP19A1 P11511 1/20 0.31
▸ GABRA1 P14867 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21975886 1.00 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10TNKSCDC14B
SCHEMBL21975899 0.99 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10TNKSCDC14B
SCHEMBL21975871 0.99 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10TNKSCDC14B
SCHEMBL21975856 0.99 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10TNKSCDC14B
SCHEMBL22435675 0.97 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10TNKSCDC14B
SCHEMBL22435667 0.96 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10TNKSCDC14B
SCHEMBL22435681 0.95 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10TNKSCDC14B
SCHEMBL22523595 0.94 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10TNKSCDC14B
SCHEMBL22435680 0.94 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10TNKSCDC14B
SCHEMBL22435677 0.93 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10TNKSCDC14B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11825740-B2 Amine compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-21 — — US disclosed
US-11825740-B2 Amine compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-21 — — US disclosed
US-20200144507-A1 AMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200144507-A1 AMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, AOC1, AOC3 PLA2G2A 3857/4885PLA2G4A 4398/4885PLA2G10 4204/4885
US-11825740-B2 Amine compound and organic light-emitting device including the same AOC2, AOC1, AOC3 PLA2G2A 3857/4885PLA2G4A 4398/4885PLA2G10 4204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback